Press Releases
Drilling For Critical Elements In The Mineral-Rich Province Of New Brunswick, Canada
Via ACCESS Newswire · December 3, 2025
By Heineken · Via GlobeNewswire · December 3, 2025
Drone Surveying Set to Grow from $1.97B to $11.49B by 2035 as ZenaTech, Inc. (NASDAQ: ZENA) Expands Its U.S. Footprint
The drone surveying market is expected to continue to gain momentum due to increasing demand for aerial intelligence and high-precision mapping across major sectors such as agriculture, mining, construction, and environmental monitoring. Fact.MR analysis indicates that the industry will be valued at USD 1.97 billion in 2025 and grow to USD 11.49 billion by 2035, at a strong CAGR of 19.3% during the period. Technological improvements in LiDAR, thermal imaging, and real-time data streaming over the past three years have dramatically improved safety and efficiency in drone surveying. Drones are increasingly being employed by governments and institutions for commercial use as they are safe, accurate, and cost-effective. Support from authorities, especially in Europe and North America, is fueling commercial usage with better regulatory frameworks.
Via AB Newswire · December 3, 2025
Metavesco Fast-Tracks OTC Prediction Market Platform
CUMMING, GA - December 3, 2025 ( NEWMEDIAWIRE ) - Metavesco, Inc . (OTC: MVCO), a diversified holding company and developer of the OTCfi ecosystem, today announced it will move directly into building the fully licensed, on-chain prediction market version of OTCfi Pulse, bypassing the previously planned sweepstakes-style beta phase.
Via TheNewswire.com · December 3, 2025
A Candid, Science-Driven Exploration of Hormones, Identity, and the ECS with Heather Reilly Hiemstra
Via ACCESS Newswire · December 3, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · December 3, 2025
The "Passenger Car Brake-by-Wire (BBW) Research Report, 2025" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · December 3, 2025
Sprinklr (NYSE: CXM), the unified customer experience management (Unified-CXM) platform for modern enterprises, today reported financial results for its third fiscal quarter ended October 31, 2025.
By Sprinklr · Via Business Wire · December 3, 2025
FiscalNote Holdings, Inc. (NYSE: NOTE), the leading provider of AI-driven policy and regulatory intelligence solutions, today announced the launch of Impact Summaries, a powerful new enhancement to its flagship PolicyNote platform. PolicyNote delivers curated, region-specific policy intelligence and monitoring to help decision-makers track and respond to developments efficiently and confidently. With Impact Summaries, users now receive immediate, organization-specific analysis detailing how legislation, regulations, and research documents could affect their operations.
By FiscalNote · Via Business Wire · December 3, 2025
CAMBRIDGE, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced topline data from its Phase 2 trial of silevertinib in frontline (1L) non-small cell lung cancer (NSCLC) patients with non-classical epidermal growth factor receptor (EGFR) mutations (NCMs) and outlined plans for a randomized Phase 2 trial of silevertinib in patients with newly diagnosed glioblastoma (ND GBM).
By Black Diamond Therapeutics, Inc · Via GlobeNewswire · December 3, 2025
LAKE ZURICH, Ill., Dec. 3, 2025 (SEND2PRESS NEWSWIRE) -- Dovenmuehle Mortgage, Inc. (DMI), a leading mortgage subservicing company, announced today that Rivermark Community Credit Union has expanded its partnership with DMI. Under this expanded relationship, Dovenmuehle will provide subservicing for Rivermark's growing portfolio of mortgage loans, supporting the credit union's expanding membership base and ensuring an exceptional servicing experience for members.
Via Send2Press · December 3, 2025
Agilitec IT has been named a finalist for two prestigious 2025 MSP Titans of the Industry Awards. The company earned finalist recognition in the AI-Powered MSP category and for the Pax8 Partner of the Year Award.
Via Press Release Distribution Service · December 3, 2025
A Heartwarming Tale Of Sounds, Smiles, And The Magic Of Togetherness.
Via PR Leap · December 3, 2025
Understanding How the Cox Communications Case May Impact Wi-Fi Providers and the Necessity of Proactive Copyright Audits
Via ACCESS Newswire · December 3, 2025
Hoggan Scientific, LLC Awarded FSS Contract Provides Direct Access To Its Medical Dynamometers for Veterans Administration Hospitals and Other Federal Government Agencies
Via ACCESS Newswire · December 3, 2025
WOBURN, MA / ACCESS Newswire / December 3, 2025 / Bridgeline Digital, Inc. (NASDAQ:BLIN), a leader in AI-powered marketing technology, announced today that its HawkSearch platform has been selected to power a new eCommerce experience for a major international provider in the material handling industry. The project will launch in partnership with a leading digital commerce agency, marking another successful collaboration within HawkSearch's growing partner ecosystem.
Via ACCESS Newswire · December 3, 2025
Vancouver, British Columbia--(Newsfile Corp. - December 3, 2025) - First Majestic Silver Corp. (NYSE: AG) (TSX: AG) (FSE: FMV) ("First...
Via Newsfile · December 3, 2025
Toronto, Ontario--(Newsfile Corp. - December 3, 2025) - Cathedra Bitcoin Inc. (TSXV: CBIT) (OTCQB: CBTTF) (the "Company", "Cathedra", "we" or...
Via Newsfile · December 3, 2025
VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared the company to proceed with the PIONEER-ALS Phase 1/2 Trial of VTx-002. VTx-002 is a first-in-class vectorized antibody targeting TDP-43 pathology in amyotrophic lateral sclerosis (ALS).
By VectorY Therapeutics · Via Business Wire · December 3, 2025
Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, today announced that Caz Hashemi and Megan Baier have been selected as the firm’s next managing partners, effective August 1, 2026. They will succeed Doug Clark, who has led the firm since 2012 and will remain in a senior advisory role through the end of the next fiscal year.
By Wilson Sonsini Goodrich & Rosati · Via Business Wire · December 3, 2025
AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, and designed for both commercial and government applications, today announced participation in the UBS Global Media and Communications Conference to be held on December 8-9, 2025 in New York.
By AST SpaceMobile, Inc. · Via Business Wire · December 3, 2025
Aeva® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced that a Top European passenger OEM has selected Aeva as its exclusive LiDAR supplier for its global series-production vehicle platform to enable Level 3 automated driving. This award follows the successful completion of a joint development program with the global Top 10 passenger OEM and marks a significant step toward bringing Aeva Atlas™ Ultra 4D LiDAR technology into large-scale production. The multi-year program spans the next decade and is expected to support multiple vehicle models across the OEM’s global platform outside of China.
By Aeva Technologies, Inc. · Via Business Wire · December 3, 2025
Uber Technologies, Inc. (NYSE: UBER) today announced that Dallas riders can now be matched with an Avride robotaxi, unlocking a brand-new way to ride with Uber.
By Uber Technologies, Inc. · Via Business Wire · December 3, 2025
Fifth Third (Nasdaq: FITB) today announced the opening of its 200th financial center in Florida and its 100th in the Carolinas—two major milestones in the Bank’s Southeast expansion. The new locations, Champions Crossing in Davenport, Florida, and Weaverville near Asheville, North Carolina, reflect Fifth Third’s commitment to delivering exceptional banking experiences and strengthening its presence in high-growth markets.
By Fifth Third · Via Business Wire · December 3, 2025
Pagaya Technologies LTD. (NASDAQ: PGY) ("Pagaya" or “the Company”), a global technology company delivering AI-driven product solutions for the financial ecosystem, today announced the closing of RPM 2025-6, a $400 million auto asset-backed securitization (ABS). The transaction marks another successful execution in Pagaya’s repeatable Auto ABS program, underscoring the Company’s ability to deliver consistent, high-quality assets to its investors.
By Pagaya Technologies LTD. · Via Business Wire · December 3, 2025
Eagle Crusher Co. will be unveiling its new Talon™ line of heavy-duty crushing and stockpiling equipment for recycling applications at CONEXPO-CON/AGG March 3-7 in Las Vegas at the Eagle Crusher Booth #C31414.
By Eagle Crusher Co. · Via Business Wire · December 3, 2025
MTFComm (https://mtfcomm.com/) today announced a major breakthrough in wireless communications: the first real-world demonstration of a new telecommunications technology that delivers 1.78 Gbps in a standard 8 MHz channel, achieving over 100× more performance than today’s wireless technologies while using only a fraction of the power.
By MTFComm · Via Business Wire · December 3, 2025
Celsius Holdings, Inc. (Nasdaq: CELH) (“Celsius Holdings” or “the Company”) today provided an update on its 2025 brand integration efforts, Alani Nu direct store delivery (DSD) transition progress, and recently achieved milestones ahead of the Company’s participation in the Morgan Stanley Global Consumer & Retail Conference.
By Celsius Holdings, Inc. · Via Business Wire · December 3, 2025
Vicarious Surgical Inc. (NYSE: RBOT, RBOT.WS) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced an update to full-year 2025 financial guidance.
By Vicarious Surgical Inc. · Via Business Wire · December 3, 2025
On December 2, the U.S. Court of Appeals for the Federal Circuit (the Federal Circuit) reversed a decision from the U.S. District Court for the Eastern District of Texas that found Seagen Inc’s U.S. Patent No. 10,808,039 (the ’039 patent) not invalid (the Texas decision). In view of the reversal, the Federal Circuit vacated the Texas court’s related infringement judgment and damages award against Daiichi Sankyo.
By Daiichi Sankyo · Via Business Wire · December 3, 2025
CAMARILLO, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- via IBN – Newton Golf Company (NASDAQ: NWTG), a leader in physics-based golf shaft technology, today announced that the Company achieved its highest single-day sales total in history on Black Friday, driven by continued demand for the Fast Motion and Motion shaft families. The Company also confirmed that November 2025 is the strongest November sales month in Newton’s history.
By Newton Golf Company · Via GlobeNewswire · December 3, 2025
First 50+ cervical cases completed; observations on initial clinical experience to be presented by early adopters at the Carlsmed CSRS Lunch Workshop
By Carlsmed · Via GlobeNewswire · December 3, 2025
Palo Alto, California, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB, MOBBW) (“Mobilicom” or the “Company”), a provider of cybersecurity and robust solutions for drones and robotics, today announced that its management will be participating in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9 and 10, 2025. Oren Elkayam, the Company’s Founder and CEO, will deliver a presentation at 3:00 PM ET on Tuesday, December 9, followed by one-on-one meetings with investors on December 10.
By Mobilicom Limited · Via GlobeNewswire · December 3, 2025
Advances electrification of calcination furnaces in the cement industry using plasma torch technology
By PyroGenesis Inc. · Via GlobeNewswire · December 3, 2025
LONDON and NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe nerve-related pain but without an FDA-approved therapy, today announces that Panetta Partners Limited, an entity in which Gabriele Cerrone, Executive Chairman has a beneficial interest, has acquired 27,051 of the Company’s ordinary shares on NASDAQ, bringing his total holding to 10,491,746 shares.
By OKYO Pharma LTD · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Tandym Group, the leader in specialized solutions for the healthcare, life sciences, technology and professional services industries, today announced the appointment of Promit Chakrabarti as Vice President of Strategic Growth and Customer Success. With nearly three decades of experience in strategic consulting, digital transformation, and enterprise-wide business and technology initiatives, Promit will play a pivotal role in advancing growth strategy for Tandym’s Consulting Solutions offering and deepening client value across its portfolio.
By Tandym Group · Via GlobeNewswire · December 3, 2025
WILMINGTON, Del., Dec. 03, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today announced that it has amended its Investigational New Drug filing for NRX-101 (D-cycloserine/lurasidone) to include the use of NRX-101 in association with Transcranial Magnetic Stimulation (TMS) for the treatment of depression, including suicidal depression.
By NRx Pharmaceuticals, Inc. · Via GlobeNewswire · December 3, 2025
SLINGERLANDS, N.Y., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, announce its participation in two upcoming investor conferences this week in New York, New York, reinforcing its commitment to ongoing engagement with the financial community.
By Plug Power, Inc. · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced G50 Corp Limited (ASX: G50; OTCQX: GFTYF), a mineral exploration company, has qualified to trade on the OTCQX® Best Market. G50 Corp Limited upgraded to OTCQX from the OTCQB® Venture Market.
By OTC Markets · Via GlobeNewswire · December 3, 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for more than 12,000 U.S. and global securities, and Moomoo, a leading global investment and trading platform with over 28 million global users, today announced a major achievement in retail investing. Moomoo officially connected OTC Markets’ MOON ATS®, delivering seamless around-the-clock market access for investors worldwide.
By OTC Markets · Via GlobeNewswire · December 3, 2025
LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) -- EVgo Inc. (NASDAQ: EVGO) (“EVgo” or the “Company”), one of the nation’s largest providers of public fast charging infrastructure for electric vehicles (EVs), has surpassed five million Autocharge+ sessions. EVgo has had sixfold growth in enrollment since 2023, with over 300,000 customers enrolled to date.
By EVgo Services LLC · Via GlobeNewswire · December 3, 2025
CAMBRIDGE, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Larkspur Biosciences, a company pioneering a new wave in cancer therapy that destroys tumors by targeting cancer cell fitness, today announced that the first participant has been dosed in the Phase 1 clinical study of its lead candidate, LRK-4189, in healthy volunteers. LRK-4189 is a first-in-class targeted protein degrader of the lipid kinase PIP4K2C being developed as a potential treatment for microsatellite stable (MSS) colorectal cancer (CRC) and other solid tumors.
By Larkspur Biosciences, Inc. · Via GlobeNewswire · December 3, 2025
WILMINGTON, Dec. 03, 2025 (GLOBE NEWSWIRE) -- ARTHUR CAPITAL INC. is pleased to announce the conclusion of its share buyback program at $4.00/share. Repurchases were made through privately negotiated transactions and shares were subsequently canceled.
By ARTHUR CAPITAL INC. · Via GlobeNewswire · December 3, 2025
The final event brings back the bestsellers by popular demand from Dec 2nd – Dec 7th
By HTVRONT · Via GlobeNewswire · December 3, 2025
Bristol Myers Squibb (NYSE: BMY, “BMS”) today announced that it will enroll additional patients in the ADEPT-2 study. As part of its commitment to upholding the highest standards in clinical research and following a thorough blinded review of the ADEPT-2 study data, the company identified irregularities due to clinical trial execution at a small number of study sites. With these findings, prior to database lock, BMS made the decision to exclude patient data from those sites from the primary analysis. Following consultation and agreement with the U.S. Food and Drug Administration (FDA), an interim data analysis for efficacy and safety was conducted by an independent party and reviewed by the Data Monitoring Committee (DMC).
By Bristol Myers Squibb · Via Business Wire · December 3, 2025
Macy’s, Inc. (NYSE: M) today reported financial results for the third quarter of 2025 and updated its annual guidance.
By Macy’s, Inc. · Via Business Wire · December 3, 2025
The "Telco Market Tracker, 2Q25: Capex pullback persists even as revenues surge 4.6%" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · December 3, 2025
In a world where digital communication dominates everything—from marketing campaigns to personal social media—we rely heavily on visuals to express our ideas. A single high-quality image can increase engagement, boost conversions, and create a powerful first impression. But taking perfect photos every time is not possible. Lighting, camera limitations, blurriness, and noise all affect photo quality.
Via GlobePRwire · December 3, 2025
ZUG, Switzerland, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced RAPIDe-3 pivotal data confirming the potential of deucrictibant’s differentiated profile for the on-demand treatment of HAE attacks. The data from Pharvaris’ first pivotal Phase 3 study will serve as the basis for marketing authorization applications, which are planned to be filed starting in the first half of 2026.
By Pharvaris N.V. · Via GlobeNewswire · December 3, 2025
New initiative aims to improve basic money skills for students, young professionals and small business owners
Via Binary News Network · December 3, 2025
